Lakewood Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,492,274
Closed -$6.31M 64
2025
Q3
$6.31M Sell
1,492,274
-2,665,000
-64% -$11.7M 0.48% 41
2025
Q2
$20.7M Sell
4,157,274
-728,473
-15% -$3.16M 1.55% 25
2025
Q1
$21.5M Hold
4,885,747
1.88% 19
2024
Q4
$22.7M Buy
4,885,747
+1,165,562
+31% +$6.41M 2.04% 19
2024
Q3
$25.8M Buy
3,720,185
+125,100
+3% +$982K 2.03% 19
2024
Q2
$28M Buy
3,595,085
+290,000
+9% +$2.15M 2.29% 16
2024
Q1
$23.5M Buy
3,305,085
+1,095,000
+50% +$7.24M 1.91% 18
2023
Q4
$14.8M Buy
2,210,085
+755,000
+52% +$4.25M 1.24% 27
2023
Q3
$8.19M Buy
1,455,085
+508,407
+54% +$3.39M 0.75% 30
2023
Q2
$5.23M Buy
+946,678
New +$5.09M 0.45% 31

Other funds holding GDRX

Lakewood Capital Management's GDRX Position: Q4 2025 in Review

Lakewood Capital Management sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 1,492,274 shares — an estimated $6.31M sold.

Lakewood Capital Management first reported a position in GDRX in Q2 2023 and held it in 10 quarters. The position peaked at $28M in Q2 2024. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • Lakewood Capital Management reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • Lakewood Capital Management sold 1,492,274 GoodRx Holdings shares in Q4 2025, an estimated $6.31M.
  • Lakewood Capital Management first reported a position in GoodRx Holdings in Q2 2023 and held it in 10 quarters.
  • Lakewood Capital Management's GoodRx Holdings position peaked at $28M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Lakewood Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.